Potential changes impacting psychiatric pharmacy by 2030.
Amy Werremeyer, Greg Payne
Author Information
- Amy Werremeyer: ���(Corresponding author) Professor and Chair, Department of Pharmacy Practice, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota, amy.werremeyer@ndsu.edu, ORCID: https://orcid.org/0000-0002-7933-4980. ORCID
- Greg Payne: ���Director of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska, ORCID: https://orcid.org/0000-0002-8592-7280. ORCID
No abstract text available.
- Health Equity. 2023 Apr 19;7(1):223-234
[PMID: 37096056]
- Ment Health Clin. 2021 Mar 31;11(2):64-69
[PMID: 33850685]
- Psychiatr Serv. 2024 Oct 1;75(10):1039-1041
[PMID: 38532688]
- Ment Health Clin. 2024 Aug 2;14(4):253-266
[PMID: 39104432]
- Ment Health Clin. 2022 Apr 14;12(2):77-85
[PMID: 35582321]
- Am J Health Syst Pharm. 2023 Nov 22;80(23):1752-1758
[PMID: 37659002]
